We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1B
AUM Growth
+$81M
Cap. Flow
+$45.6M
Cap. Flow %
4.55%
Top 10 Hldgs %
62.52%
Holding
4,698
New
814
Increased
789
Reduced
1,481
Closed
1,566

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$13.3M
2
MSFT icon
Microsoft
MSFT
+$11.7M
3
XOM icon
ExxonMobil
XOM
+$10.9M
4
BAC icon
Bank of America
BAC
+$8.84M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.82M

Sector Composition

Rank Sector Weight
1 Financials 1.65%
2 Technology 1.48%
3 Materials 1.36%
4 Healthcare 1.28%
5 Industrials 1.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIPT icon
2851
Tiptree Inc
TIPT
$667M
$1K ﹤0.01%
+180
New +$1.18K
TRAK icon
2852
ReposiTrak
TRAK
$158M
$1K ﹤0.01%
100
-2,029
-95% -$27.9K
TREE icon
2853
LendingTree
TREE
$447M
$1K ﹤0.01%
9
-207
-96% -$23.6K
TRIB
2854
Trinity Biotech
TRIB
$7.86M
$1K ﹤0.01%
1
-1
-50% -$938
TTEK icon
2855
Tetra Tech
TTEK
$8.89B
$1K ﹤0.01%
110
-8,775
-99% -$72.7K
TV icon
2856
Televisa
TV
$1.5B
$1K ﹤0.01%
51
-1,233
-96% -$29.2K
UG icon
2857
United-Guardian
UG
$33.2M
$1K ﹤0.01%
+70
New +$1.06K
UTL icon
2858
Unitil
UTL
$981M
$1K ﹤0.01%
+22
New +$988
UVSP icon
2859
Univest Financial
UVSP
$1.21B
$1K ﹤0.01%
21
-438
-95% -$12.3K
VCYT icon
2860
Veracyte
VCYT
$3.71B
$1K ﹤0.01%
100
-486
-83% -$3.98K
VGZ icon
2861
Vista Gold
VGZ
$296M
$1K ﹤0.01%
800
-700
-47% -$723
VSHY icon
2862
Virtus Newfleet Short Duration High Yield Bond ETF
VSHY
$31M
$1K ﹤0.01%
+34
New +$851
VVX icon
2863
V2X
VVX
$2.65B
$1K ﹤0.01%
50
-204
-80% -$4.68K
WK icon
2864
Workiva
WK
$3.38B
$1K ﹤0.01%
49
-796
-94% -$11.2K
WNEB icon
2865
Western New England Bancorp
WNEB
$282M
$1K ﹤0.01%
51
-1,593
-97% -$15.7K
WVVI icon
2866
Willamette Valley Vineyards
WVVI
$12M
$1K ﹤0.01%
100
-203
-67% -$1.61K
ZSL icon
2867
ProShares UltraShort Silver
ZSL
$55.6M
0
ZVRA icon
2868
Zevra Therapeutics
ZVRA
$705M
$1K ﹤0.01%
16
-40
-71% -$2.43K
PVLA
2869
Palvella Therapeutics
PVLA
$2.23B
$1K ﹤0.01%
+3
New +$531
EQC
2870
DELISTED
Equity Commonwealth
EQC
$1K ﹤0.01%
47
-253
-84% -$7.85K
SYRS
2871
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1K ﹤0.01%
5
+2
+67% +$244
INFN
2872
DELISTED
Infinera Corporation Common Stock
INFN
$1K ﹤0.01%
54
-6,743
-99% -$67.6K
AUMN
2873
DELISTED
Golden Minerals Company
AUMN
$1K ﹤0.01%
60
-72
-55% -$1.17K
SRCL
2874
DELISTED
Stericycle Inc
SRCL
$1K ﹤0.01%
14
-2,206
-99% -$177K
HMNF
2875
DELISTED
HMN Financial Inc
HMNF
$1K ﹤0.01%
+47
New +$849

Similar funds

Tower Research Capital (TRC)'s Q1 2017 Portfolio in Review

As of Q1 2017, Tower Research Capital (TRC) held 4,698 positions worth $1B, up 8.8% from $921M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Tower Research Capital (TRC) deployed $45.6M of net new capital in Q1 2017, opening 814 new positions and adding to 789 existing holdings. Its largest new stake was ProShares Ultra Russell2000: 717,004 shares worth $20.7M.

By sector, the portfolio is most concentrated in Financials at 1.7% of assets, down from 14% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Apple, an estimated $13.3M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2017 buy was ProShares Ultra Russell2000: 717,004 shares worth $20.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $213M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2017 reduction was Apple, cutting an estimated $13.3M.
  • Tower Research Capital (TRC) fully exited Berkshire Hathaway Class B in Q1 2017, selling an estimated $8.82M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 63% of its $1B portfolio in Q1 2017.
  • Tower Research Capital (TRC) opened 814 new positions and closed 1,566 in Q1 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 8.8% quarter-over-quarter to $1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2017, filed 19 May 2017.